RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shanna Burke to Alzheimer Disease

This is a "connection" page, showing publications Shanna Burke has written about Alzheimer Disease.
Connection Strength

3.698
  1. Burke S, Grudzien A, Li T, Abril M, Spadola C, Barnes C, Hanson K, Grandner M, DeKosky S. Correlations between sleep disturbance and brain structures associated with neurodegeneration in the National Alzheimer's Coordinating Center Uniform Data Set. J Clin Neurosci. 2022 Dec; 106:204-212.
    View in: PubMed
    Score: 0.526
  2. Burke SL, Hu T, Naseh M, Fava NM, O'Driscoll J, Alvarez D, Cottler LB, Duara R. Factors influencing attrition in 35 Alzheimer's Disease Centers across the USA: a longitudinal examination of the National Alzheimer's Coordinating Center's Uniform Data Set. Aging Clin Exp Res. 2019 Sep; 31(9):1283-1297.
    View in: PubMed
    Score: 0.408
  3. Burke SL, Hu T, Spadola CE, Burgess A, Li T, Cadet T. Treatment of Sleep Disturbance May Reduce the Risk of Future Probable Alzheimer's Disease. J Aging Health. 2019 02; 31(2):322-342.
    View in: PubMed
    Score: 0.400
  4. Burke SL, Hu T, Fava NM, Li T, Rodriguez MJ, Schuldiner KL, Burgess A, Laird A. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging. 2019 Mar-Apr; 31(2):140-164.
    View in: PubMed
    Score: 0.383
  5. Burke SL, Cadet T, Alcide A, O'Driscoll J, Maramaldi P. Psychosocial risk factors and Alzheimer's disease: the associative effect of depression, sleep disturbance, and anxiety. Aging Ment Health. 2018 12; 22(12):1577-1584.
    View in: PubMed
    Score: 0.378
  6. Burke SL, Maramaldi P, Cadet T, Kukull W. Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry. 2018 Jan; 33(1):200-211.
    View in: PubMed
    Score: 0.367
  7. Burke SL, O'Driscoll J, Alcide A, Li T. Moderating risk of Alzheimer's disease through the use of anxiolytic agents. Int J Geriatr Psychiatry. 2017 12; 32(12):1312-1321.
    View in: PubMed
    Score: 0.353
  8. Burke SL, Maramaldi P, Cadet T, Kukull W. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development. Arch Gerontol Geriatr. 2016 Jul-Aug; 65:231-8.
    View in: PubMed
    Score: 0.339
  9. Burke SL, Maramaldi P, Cadet T, Kukull W. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia. Int Psychogeriatr. 2016 09; 28(9):1409-24.
    View in: PubMed
    Score: 0.338
  10. Rodriguez M, Mendoza L, Rodriguez I, Rosselli M, Loewenstein D, Burke S, Orozco A, Duara R. Cultural factors related to neuropsychological performance and brain atrophy among Hispanic older adults with amnestic Mild Cognitive Impairment (aMCI): A pilot study. Appl Neuropsychol Adult. 2022 May-Jun; 29(3):364-372.
    View in: PubMed
    Score: 0.113
  11. Burke SL, Cadet T, Maddux M. Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc. 2018 Aug; 110(4):314-325.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support